BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38266515)

  • 1. Unveiling mortality risk factors in paediatric sickle cell disease patients during acute crises in the Democratic Republic of the Congo.
    Boma PM; Ngimbi SL; Kindundu JM; Wela JI; Ngoie NL; Ngwamah VM; Tshiswaka SM; Monga JK; Panda JM; Bonnechère B
    Blood Cells Mol Dis; 2024 Mar; 105():102828. PubMed ID: 38266515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of sickle cell disease: current practices and challenges in a northeastern region of the Democratic Republic of the Congo.
    Kambale-Kombi P; Marini Djang'eing'a R; Alworong'a Opara JP; Minon JM; Boemer F; Bours V; Tonen-Wolyec S; Kayembe Tshilumba C; Batina-Agasa S
    Hematology; 2021 Dec; 26(1):199-205. PubMed ID: 33594960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenge of managing sickle cell disease in a pediatric population living in kinshasa, democratic republic of congo: a sickle cell center experience.
    Aloni MN; Nkee L
    Hemoglobin; 2014; 38(3):196-200. PubMed ID: 24669956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Students' knowledge on sickle cell disease in Kisangani, Democratic Republic of the Congo.
    Kambale-Kombi P; Marini Djang'eing'a R; Alworong'a Opara JP; Tonen-Wolyec S; Kayembe Tshilumba C; Batina-Agasa S
    Hematology; 2020 Dec; 25(1):91-94. PubMed ID: 32070266
    [No Abstract]   [Full Text] [Related]  

  • 5. Sickle Cell Disease in the Democratic Republic of Congo: Assessing Physicians' Knowledge and Practices.
    Mukinayi Mbiya B; Tumba Disashi G; Gulbis B
    Trop Med Infect Dis; 2020 Jul; 5(3):. PubMed ID: 32751148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Digestives diseases associated to sickle cell anemia in Lubumbashi: epidemiological and clinical aspects].
    Banza MI; Mulefu JP; Lire LI; N'dwala YTB; Tshiamala IB; Cabala VPK
    Pan Afr Med J; 2019; 33():253. PubMed ID: 31692839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Red blood cell alloimmunisation in sickle cell disease patients in the Democratic Republic of the Congo.
    Kambale-Kombi P; Djang'eing'a RM; Alworong'a Opara JP; Minon JM; Sepulchre E; Bours V; Floch A; Pirenne F; Tshilumba CK; Batina-Agasa S
    Transfus Med; 2023 Apr; 33(2):137-146. PubMed ID: 36377544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview of current progress and challenges in diagnosis, and management of pediatric sickle cell disease in Democratic Republic of the Congo.
    Kasai ET; Alworong'a Opara JP; Ntokamunda Kadima J; Kalenga M; Batina Agasa S; Marini Djang'eing'a R; Boemer F
    Hematology; 2022 Dec; 27(1):132-140. PubMed ID: 35068390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knowledge and practices of sickle cell disease among healthcare providers in Kinshasa, Democratic Republic of the Congo.
    Ngonde AM; Fina JL; Burgueno E; Lukanu PN
    Afr J Prim Health Care Fam Med; 2024 Feb; 16(1):e1-e8. PubMed ID: 38426772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of SCD morbimortality in children: experience in a remote area of an African country.
    Mbiya BM; Kalombo DK; Mukendi YN; Daubie V; Mpoyi JK; Biboyi PM; Disashi GT; Gulbis B
    BMC Health Serv Res; 2021 Apr; 21(1):294. PubMed ID: 33794895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of sickle cell disease in a northeastern region of the Democratic Republic of Congo: what impact on transfusion policy?
    Agasa B; Bosunga K; Opara A; Tshilumba K; Dupont E; Vertongen F; Cotton F; Gulbis B
    Transfus Med; 2010 Feb; 20(1):62-5. PubMed ID: 19712051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of sickle cell disease in a pediatric population suffering from severe infections: a Congolese experience.
    Kondani DA; Gini-Ehungu JL; Bodi JM; Ekulu PM; Kunuanunua TS; Aloni MN
    Hemoglobin; 2014; 38(4):225-9. PubMed ID: 25023084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of biofield therapy for individuals with sickle cell disease in Africa.
    Minga TM; Koto FK; Egboki H; Suzuki K
    Altern Ther Health Med; 2014; 20(1):20-6. PubMed ID: 24445353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Awareness and attitudes of 50 congolese families affected by sickle cell disease: a local survey].
    Mukinayi BM; Kalenda DK; Mbelu S; Gulbis B
    Pan Afr Med J; 2018; 29():24. PubMed ID: 29875906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Newborn screening for sickle cell disease in Butembo and Beni: a pilot experience in a highland region of the Democratic Republic of Congo.
    Mumbere M; Batina-Agasa S; Uvoya NA; Kasai ET; Kombi PK; Djang'eing'a RM; Opara JA
    Pan Afr Med J; 2023; 45():56. PubMed ID: 37637401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malaria, clinical features and acute crisis in children suffering from sickle cell disease in resource-limited settings: a retrospective description of 90 cases.
    Aloni MN; Tshimanga BK; Ekulu PM; Ehungu JL; Ngiyulu RM
    Pathog Glob Health; 2013 Jun; 107(4):198-201. PubMed ID: 23816320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical characteristics of Congolese children and adolescents suffering from sickle-cell anemia are marked by the high frequencies of epistaxis compared to Western series.
    Kazadi AL; Ngiyulu RM; Gini-Ehungu JL; Mbuyi-Muamba JM; Aloni MN
    Pediatr Hematol Oncol; 2019 Aug; 36(5):267-276. PubMed ID: 31339399
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute Crises and Complications of Sickle Cell Anemia Among Patients Attending a Pediatric Tertiary Unit in Kinshasa, Democratic Republic Of Congo.
    Aloni MN; Kadima BT; Ekulu PM; Budiongo AN; Ngiyulu RM; Gini-Ehungu JL
    Hematol Rep; 2017 Jun; 9(2):6952. PubMed ID: 28626540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [HemoTypeSC screening for sickle cell disease in the Democratic Republic of Congo (DRC): a case from the city of Kindu].
    Aimé AK; Etienne SM; Mbongi D; Nsonso D; Serrao E; Léon TMM; Oscar LN; Stanis WO
    Pan Afr Med J; 2022; 41():134. PubMed ID: 35519159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interventions for preventing silent cerebral infarcts in people with sickle cell disease.
    Estcourt LJ; Kimber C; Hopewell S; Trivella M; Doree C; Abboud MR
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD012389. PubMed ID: 32250453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.